Bonyf N.V. Logo

Bonyf N.V.

Develops medical devices for oral, dental, orthodontic, and dermatological care.

MLBON | BR

Overview

Corporate Details

ISIN(s):
BE6333353298
LEI:
699400NGN0HE0QBIF505
Country:
Belgium
Address:
Doornzelestraat 114 bus D, 9000 Gent

Description

Bonyf N.V. is a company specializing in the research, development, production, and distribution of products for oral, dental, orthodontic, and dermatological care. The company develops clinically validated solutions for dental professionals, pharmacies, and consumers. Its portfolio includes care products for removable oral appliances such as dentures, retainers, and orthodontic devices. Key innovations are based on its patented NitrAdine® formulation, which is used in products like disinfecting tablets and PerioCream, a mucoadhesive paste for professional periodontal treatment. Bonyf focuses on providing high-quality, certified medical device solutions to improve patient well-being.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-15 15:23
bonyf AG receives the EU-MDR Certification Class IIa for PerioCream
English 19.5 KB
2025-09-15 17:28
bonyf NV Showcases Innovative Product Portfolio at ExpoPharm 2025 in Dusseldorf
English 16.3 KB
2025-09-05 10:51
bonyf NV Cancels Planned Capital Increase Following Positive Strategic Developm…
English 15.3 KB
2025-08-11 15:16
Periocream: The Future Commercial Winner for bonyf
English 17.8 KB
2025-07-14 17:43
bonyf Reaffirms Its Long-Term Vision Amid Short-Term Market Volatility
English 21.7 KB
2025-06-30 21:18
Annual Results 2024
English 12.4 KB

Automate Your Workflow. Get a real-time feed of all Bonyf N.V. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Bonyf N.V.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Bonyf N.V. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-05-15 Bogaert Jean-Pierre Executive member Sell 4,900 82,810.00 EUR
2025-05-01 Bogaert Jean-Pierre Executive member Sell 3,782 66,563.20 EUR
2025-03-06 Bogaert Jean-Pierre Executive member Sell 15,000 262,500.00 EUR
2025-02-26 Bogaert Jean-Pierre Executive member Sell 3,128 59,432.00 EUR
2025-02-21 Bogaert Jean-Pierre Executive member Sell 1,986 36,741.00 EUR
2025-02-13 Bogaert Jean-Pierre Executive member Sell 6,030 108,540.00 EUR
2025-02-12 Bogaert Jean-Pierre Executive member Sell 1,300 24,700.00 EUR
2024-12-30 Bogaert Jean-Pierre Executive member Sell 1,400 25,200.00 EUR
2024-12-20 Bogaert Jean-Pierre Executive member Sell 1,250 23,750.00 EUR
2024-12-17 Bogaert Jean-Pierre Executive member Sell 1,700 32,300.00 EUR

Peer Companies

Aldeyra Therapeutics, Inc. Logo
Develops medications for immune-mediated ocular and systemic diseases.
United States of America
ALDX
Alector, Inc. Logo
Clinical-stage biotech using immuno-neurology to treat neurodegenerative diseases.
United States of America
ALEC
ALK-Abelló Logo
A pharmaceutical company specializing in allergy prevention, diagnosis, and treatment.
Denmark
ALK
Alkaloid AD Logo
Manufactures generic pharmaceuticals, cosmetics, and chemical products.
North Macedonia
ALK
Alkermes plc. Logo
Develops and commercializes medicines for central nervous system (CNS) diseases.
United States of America
ALKS
Allarity Therapeutics, Inc. Logo
A clinical-stage biopharma using diagnostics to develop targeted cancer therapies.
United States of America
ALLR
ALLERGY THERAPEUTICS PLC Logo
Immunology company developing aluminum-free vaccines and therapies for allergies.
United Kingdom
AGY
Alligator Bioscience Logo
Clinical-stage biotech developing tumor-directed immuno-oncology antibody drugs.
Sweden
ATORX
Allogene Therapeutics, Inc. Logo
Develops off-the-shelf allogeneic CAR T therapies for cancer and autoimmune diseases.
United States of America
ALLO
Almirall S.A. Logo
Global biopharmaceutical company specializing in medical dermatology and skin health.
Spain
ALM

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.